Cardiomyopathy FAQ
Cardiomyopathy FAQ
The clinical questions in cardiomyopathy are answered by the tests; the practical ones are answered by planning. This page deals with the second kind: how a written estimate is built and why no fixed price is quoted before the records are read, how long a visit of each kind usually requires, which records actually change the plan and in what form they should be sent, when a flight should wait, how direct billing works and what is usually excluded, how follow-up continues once the patient is home, and what a companion should know before the journey starts.
Costs and how an estimate is built
No fixed price is quoted before the records are reviewed, and the reason is practical rather than evasive. Cardiomyopathy care spans everything from an assessment that concludes with medication and a monitoring plan to device implantation, septal reduction or advanced surgical options — and an honest estimate follows the plan rather than preceding it. What is quoted is a written, itemised estimate: hospital stay, investigations, devices, medicines and the follow-up arrangements, issued after the records review and before anything is booked.
Complete treatment in China typically runs at 30–50% of comparable care in Europe or the United States, and the estimate is what makes that difference visible in figures rather than leaving it to be discovered afterwards. Two things are worth knowing about how it is built. Investigations that have already been done properly at home are not repeated without a reason, so sending the images is also what keeps the estimate honest. And where the assessment concludes that no procedure is needed, the cost of the visit is the cost of the assessment itself — a legitimate outcome rather than a wasted journey.
How long to plan for
The length of a visit depends on what has to be decided and on what has to be done, and the two are not always the same. The table below sets out planning figures by purpose of visit; they are revised as soon as the assessment is complete.
| Purpose of the visit | Usual planning | What decides the length |
|---|---|---|
| Assessment only | A few days | Whether imaging has to be repeated, whether a genetic test is being arranged, and whether the written opinion is discussed in person or by video |
| Diagnostic admission (catheterisation, biopsy or a rhythm study) | Under a week | Which investigations the assessment needs, and how quickly the patient recovers from any procedure that forms part of them |
| Device implantation (defibrillator or resynchronisation) | About a week to ten days | The observation period after implantation, the device check before discharge, and the advice about driving and follow-up that has to be settled first |
| Septal reduction or cardiac surgery | Two to three weeks | The recovery milestones set by the team, the medication plan settled before discharge, and fitness for a long flight |
| Advanced assessment (transplant or mechanical support pathway) | Planned individually | The investigations the assessment requires; these visits are arranged around the programme rather than around a standard package |
What is not counted in these figures is the follow-up, which continues at home and can largely be done remotely. For most patients the visit is a concentrated period and the years afterwards are the longer part of the care — which is why the follow-up plan is agreed in writing before departure rather than left to be arranged later.
What to send, and in what form
The most useful thing a patient can send is the images themselves. Cardiomyopathy is diagnosed from imaging and from the electrical record, and a written report that says "hypertrophic cardiomyopathy with moderately reduced function" cannot answer which segments are thickened, how much scar is present or whether the rhythm was normal. A review based on reports alone ends with a request for the images — so sending them at the start is what saves the first week.
- Echocardiogram images and report — discs or DICOM files, with the date. Earlier studies are worth sending too, because the trend matters as much as the current picture.
- Cardiac MRI — the disc itself rather than only the report, because the tissue characterisation and the scar are read from the images.
- ECG tracings, and any Holter or event-monitor report — tracings as well as the interpretation, since the pattern is what is being assessed.
- Blood results — NT-proBNP, troponin, kidney and liver function, iron studies, and the results of any protein electrophoresis or free light chain testing.
- Any genetic report, with the variant described — a positive result changes what relatives are offered, and a variant of uncertain significance is worth sending even though it explains less.
- The family history and the medication list — written down, with the reason each drug was started, changed or stopped.
Complete records that arrive as a set are reviewed by a cardiology team and answered with a written opinion within about 48 hours of arrival. Records that arrive in pieces take longer — not because the review is slower, but because the picture cannot be read until the pieces are together. In practice, the single most common cause of delay is an MRI or an echocardiogram that was reported but never sent.
When it is safe to fly, and when it is not
Most patients with cardiomyopathy travel without difficulty, and a stable diagnosis is not by itself a reason to cancel a trip. There are situations in which the flight should wait, and in this disease the list deserves to be stated plainly.
Defer travel if any of these apply: a fainting spell that has not yet been explained, or fainting during exertion — that assessment belongs where you are, not at the end of a flight; a recent dangerous rhythm, or an admission still inside its settling window; decompensated heart failure — breathlessness at rest, rapidly increasing swelling, or a weight that has climbed over a few days; chest pain at rest or escalating; an active infection or fever; a device implanted within the period your team advises; or a medication change that has been planned but not yet made and reviewed, particularly in obstructive disease, where the wrong change can worsen the gradient.
Two points deserve a note. A planned visit and an urgent one are different journeys: if a red flag appears while waiting to travel, the assessment should happen locally first and the trip arranged afterwards around the answer — deferral is a safety decision, not a cancellation. And travel is much easier when the records travel too: a written summary of the type, the pump function, the rhythm risk and the current medication turns a visit to an emergency department in an unfamiliar city from a puzzle into a short conversation.
Insurance, direct billing and what is usually excluded
We work with more than 30 commercial insurers for direct billing: where the policy covers the treatment, settlement is arranged between the hospital and the insurer rather than paid in advance and reclaimed. Whether it applies depends on the policy, on pre-authorisation and on the exclusions, so the practical step is to send the policy details with the records and to confirm coverage before travel. Our international patients have come from 124 countries and regions, and for most of them the insurance paperwork is routine rather than exceptional.
Three categories are commonly excluded and worth checking early. Pre-existing conditions: a heart muscle problem diagnosed or investigated before the policy began is usually treated differently from a new event. Devices: defibrillators and resynchronisation systems are sometimes capped, or excluded separately from the procedure that implants them. Genetic testing and family screening: these are often classified as preventive rather than as treatment, and are frequently not covered at all — which matters more in this disease than in most, because screening relatives is part of the treatment rather than an optional extra.
Where a policy does not cover the treatment, the written estimate still does its work: it sets out what is included, what is not, and what could change the total, before any commitment is made on either side.
After you fly home: the follow-up that survives the journey
Follow-up after cardiomyopathy care runs on two lines with different schedules. The clinical line — imaging, rhythm assessment, medication review and the question of a device — is set out in a written plan before the patient flies home, with the first review arranged remotely and the tests repeated at intervals decided by the type of disease rather than by distance. The family line — who is being screened, by whom, and when the next round is due — is the one most often lost in the journey, which is why it is worth naming the person responsible for it before departure rather than after.
Two arrangements make the difference in practice. The first is a written summary in a form a local cardiologist can actually use: the type, the imaging findings, the pump function, the rhythm risk, the current medication with doses, and the monitoring interval. The second is an agreed threshold for coming back, decided before the flight rather than improvised afterwards — which symptoms would justify the journey, and which can be handled by a video review or by the local team working from our opinion in writing.
Companions and the practicalities of the visit
For an assessment visit or a diagnostic admission, one companion is usually enough and is genuinely useful — for the conversations, for the journey home, and for remembering instructions that arrive at the same time as a new medication plan. Around device implantation or cardiac surgery, a companion is close to essential for the first weeks after discharge, and it should be the person who will actually be present then rather than the person who happens to be available for the first few days.
Our international patient team arranges the medical visa documents from the hospital side, translation throughout the visit, and the practicalities of the stay; travel and accommodation support is described on the travel concierge page. Three things are worth planning before arrival rather than on it: who will be present after discharge, whether the companion needs their own visa documentation, and how the family history will be collected — because in this disease the companion is often the one person who knows which relative was paced, which one drowned while swimming, and which one died suddenly, and at what age.